Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03121261Phase 4Active, not recruiting
Phase 4 trial of clonidine in inguinal hernia (2 arms), sponsored by Dubrava University Hospital. Primary endpoint: Duration of Latency and duration of the cutaneous silent period at 24 hours. Started May 2017; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03121261.